CNS pipeline · person

Paola Casarosa, PhD

Member of the Board of Managing Directors of Boehringer Ingelheim with responsibility for the Innovation Unit (research and development), appointed to the Board on 1 July 2023 and assuming the Innovation Unit on 1 January 2024. Her earlier roles at the company included Therapeutic Area Head for CNS, Retinopathies and Emerging Diseases; she holds a PhD in molecular pharmacology from VU Amsterdam.

1 company

Current roles

Boehringer Ingelheim International GmbHMember of the Board of Managing Directors (Innovation Unit / R&D) · Executive2023–present

Appears with

People sharing a company with Paola.

Hubertus von Baumbach · Boehringer Ingelheim International GmbH
Shashank Deshpande · Boehringer Ingelheim International GmbH

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.